Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Steroid Functionalization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced steroid synthesis route for Fulvestrant eliminates aromatic ring construction, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Analysis of patent CN103387595A reveals a chromium-free prednisolone synthesis route offering high purity, simplified workup, and significant cost reduction potential.
Novel aldol condensation route for obeticholic acid intermediate. High yield, scalable process offering cost reduction in API manufacturing and supply chain reliability.
Advanced synthesis of loteprednol etabonate intermediate via 11-alpha-hydroxy-ADD. High purity, cost-effective route for ophthalmic steroid manufacturing.
Patent CN103788164A reveals a scalable route for fulvestrant using stable isothiourea reagents, offering significant cost reduction and high-purity API intermediate manufacturing capabilities.
Advanced synthesis of 16β-methyl steroid intermediates via novel dehydration and epoxidation. Cost-effective route for Betamethasone precursors ensuring high purity.
Patent CN112010918A details a novel cyanation route for 17-beta-hydroxy steroids, eliminating toxic mercury catalysts and enabling high-purity impurity reference standards for pharmaceutical quality control.
Discover the novel synthetic route for Ulipristal Acetate via patent CN102875629A. Achieve significant cost reduction and enhanced supply chain reliability in steroid manufacturing.
Patent CN111362999B details a novel oxidation method for Epristeride impurity. This report analyzes cost reduction in API manufacturing and high-purity reference standard production.
Patent CN110172078B details efficient synthesis of 19-hydroxycortodoxone derivatives. Offers cost reduction in pharmaceutical intermediate manufacturing via optimized side-chain cleavage.
High-yield synthesis of 5α-androst-7-methyl intermediates via catalytic hydrogenation and Wittig reaction. Reliable supply chain for steroid manufacturing.
Discover the novel 4-step synthesis of 16α-hydroxyprednisolone from patent CN111253457A. Achieve >99.5% purity with reduced costs and scalable pharmaceutical intermediate production.
Patent CN104098639A details a cost-effective, high-yield route for 17beta-carboxyl-4-androstene-3-ketone, optimizing supply chain reliability for Finasteride intermediates.
Discover the novel preparation method for 16 beta alkyl steroids via CN107746420B. Achieve superior selectivity and yield for pharmaceutical intermediates with reduced costs.
Patent CN102827230A details a green 5-step route to Hydrocortisone Acetate avoiding toxic pyridine and heavy metals, ensuring >98.5% purity and scalable production for reliable API supply chains.
Novel chromium-free oxidation method for cortisone intermediates ensuring greater than 99 percent purity and zero heavy metal waste.
Discover a novel SO2-catalyzed synthesis for high-purity mometasone furoate. This patent-backed process offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101397323A details a novel chemical synthesis of hydrocortisone from 17-hydroxyl-4,9-diene intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103641879A details a novel chemical route for prednisolone intermediates using plant sterols, offering significant cost reduction and high purity for pharmaceutical manufacturing.